Fundraising Fox

Maina Bhaman

Investor

Partner at Sofinnova Partners

London

Writes $100K – $5M checks · typically $1.5M

About

Maina Bhaman is a Partner in Sofinnova's Capital Strategy, who joined in 2018 with a background as a healthcare investor. She previously served as director of healthcare investment at Touchstone Innovations (formerly Imperial Innovations) in London and earlier worked in R&D at biotech companies including Celltech and Oxford GlycoSciences. She holds a BSc from the University of Texas at Austin and an MBA from Imperial Business School.

LinkedIn ↗Website ↗

Invests in

BiotechMedical Devices

Experience

  1. Sofinnova PartnersPartnercurrent2018 — presentParis Area, France
  2. PsiOxus TherapeuticsInvestor Director2010 — 2017
  3. CellmedicaNon-Exec Director2007 — 2017
  4. Touchstone InnovationsDirector- Healthcare Investments2006 — 20177 Air Street, london
  5. Molecular VisionNon-Exec Director2007 — 2012
  6. Independent consultant2005 — 2006
  7. Celltech R&DScientist2004 — 2005
  8. Oxford GlycoSciencesScientist2002 — 2004
  9. Chimeric Therapies IncScientist1997 — 2002
  10. GeneMedicineScientist1994 — 1997

Education

  1. Imperial College LondonMBA2004 — 2006
  2. The University of Texas at AustinBSc, Biochemistry1992 — 1994

Skills & more

Biotechnology27Medical Devices8Strategic Consulting4Lifesciences8Venture Capital13Entrepreneurship4Start-ups38

From Maina's professional profile.

Same school

Also attended Imperial College London295

Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi

+ 289 more

Also attended The University of Texas at Austin247

Viswa SankaranarayananVenture Partner at Monta Vista CapitalTodd KleinManaging Partner, Revolution Growth at RevolutionSapna MehtaInvestor at RevolutionAaron LiuPrincipal at NorthzoneAndrew ScottSenior Finance Manager at GreycroftMichael HsuSenior Associate at Sapphire Ventures

+ 241 more

Shared employers

Also worked at PsiOxus Therapeutics1

Karen LaRochelleVenture Partner at Advent Life Sciences

Deals · 1

Mediar TherapeuticsBoard seat

via Sofinnova Partners · filed Dec 2025 · $75.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Sofinnova Partners

Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners